Prolacta’s 100% Human Milk-Based Fortifiers Lower the Risk of Multiple Complications and Death Among Preterm Infants, Compared to Fortifiers Made From Cow Milk, Says New Study
September 08, 2020 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a new...
Research Suggests Some Premature Infants May Go Home From the NICU Up To Three Weeks Earlier When Fed Prolacta’s 100% Human Milk-Based Nutritional Products; Those with Bronchopulmonary Dysplasia May Benefit the Most
July 30, 2020 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- A retrospective study indicates that premature infants’ stays in neonatal intensive care units (NICUs) are reduced anywhere from 4.5 to 22.9 days...
Multiple NICUs Showed Improved Growth & Lung Health in Premature Infants by Fortifying Feeds Safely in the First Days of Life with Prolacta’s 100% Human Milk-Based Fortifiers
July 14, 2020 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of an...
The Preemie Parent’s Survival Guide to the NICU Now Reflects the Latest Clinical Advancements to Better Support Parents Worldwide
June 24, 2020 09:05 ET
|
PreemieWorld
WASHINGTON, June 24, 2020 (GLOBE NEWSWIRE) -- PreemieWorld and Prolacta Bioscience are proud to announce publication of the updated second edition of The Preemie Parent’s Survival Guide to the...
Preterm Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers Achieved Catch-Up Growth by Age 2 with Appropriate Neurodevelopmental Outcomes, Study Says
June 01, 2020 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a...
Head-to-Head Subgroup Analysis of Human Milk–Based Fortifiers Finds Significant Improvements in Health and Brain Growth Measure for Preemies Fed Mother’s Milk Plus Prolacta’s Fortifiers
May 12, 2020 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk–based nutritional products, announced today that a subgroup analysis...
UPDATE - Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
April 02, 2020 23:55 ET
|
Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience,® the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
April 02, 2020 15:50 ET
|
Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
Prolacta Bioscience Congratulates Terry Johnson for Lifetime Achievement Award in Neonatal Nursing
November 21, 2019 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, is proud to announce that one of its...
Despite Worsening Prematurity Birth Rate, Odds of Survival Improving with NICU Adoption of Prolacta’s 100% Human Milk-Based Fortifiers
November 19, 2019 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, is helping neonatal intensive care units...